Tissue factor, lipid rafts, and microparticles

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 8, 2010, Pages 857-864

  Davizon, Pavel ^a   Munday, Adam D ^a   López, José A ^a,b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cancer; lipid rafts; microparticles; thrombosis; Tissue factor

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; THROMBOPLASTIN;

HUMAN; HYPERLIPIDEMIA; LIPID RAFT; MEMBRANE BIOLOGY; MEMBRANE STRUCTURE; NEOPLASM; NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

CELL MEMBRANE; CELL-DERIVED MICROPARTICLES; HUMANS; MEMBRANE MICRODOMAINS; THROMBOPLASTIN;

EID: 78149287599     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1267039     Document Type: Review

References (84)

1. Ruf W, Furlan-Freguia C, Niessen F. Vascular and dendritic cell coagulation signaling in sepsis progression. J Thromb Haemost 2009 7 (Suppl 1) 118-121
2. Morris D R., Ding Y, Ricks T K., Gullapalli A, Wolfe B L., Trejo J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 2006 66 (1) 307-314
3. Riewald M, Ruf W. Orchestration of coagulation protease signaling by tissue factor. Trends Cardiovasc Med 2002 12 (4) 149-154
4. Hembrough T A., Swartz G M., Papathanassiu A et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 2003 63 (11) 2997-3000
5. Khorana A A., Ahrendt S A., Ryan C K. et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 2007 13 (10) 2870-2875
6. De Blaineville H MD. Injection de matire cérébrale dans des veines. Gazette Medical Paris 1834 2 524
7. Morawitz P. Die Chemie der Blutgerinnung. Ergeb Physiol 1905 4 307-422
8. Howell W H. Theories of blood coagulation. Physiol Rev 1935 15 435-470
9. Bchli E. History of tissue factor. Br J Haematol 2000 110 (2) 248-255
10. Broze G J. Jr, Leykam J E., Schwartz B D., Miletich J P. Purification of human brain tissue factor. J Biol Chem 1985 260 (20) 10917-10920
11. Fisher K L., Gorman C M., Vehar G A., O'Brien D P., Lawn R M. Cloning and expression of human tissue factor cDNA. Thromb Res 1987 48 (1) 89-99
12. Morrissey J H., Fakhrai H, Edgington T S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987 50 (1) 129-135
13. Scarpati E M., Wen D, Broze G J. Jr et al. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987 26 (17) 5234-5238
14. Spicer E K., Horton R, Bloem L et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A 1987 84 (15) 5148-5152
15. Mackman N, Morrissey J H., Fowler B, Edgington T S. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 1989 28 (4) 1755-1762
16. Edgington T S., Ruf W, Rehemtulla A, Mackman N. The molecular biology of initiation of coagulation by tissue factor. Curr Stud Hematol Blood Transfus 1991 (58) 15-21
17. Morrissey J H., Gregory S A., Mackman N, Edgington T S. Tissue factor regulation and gene organization. Oxf Surv Eukaryot Genes 1989 6 67-84
18. Chen V M., Ahamed J, Versteeg H H., Berndt M C., Ruf W, Hogg P J. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006 45 (39) 12020-12028
19. Dorfleutner A, Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 2003 102 (12) 3998-4005
20. Bach R, Konigsberg W H., Nemerson Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry 1988 27 (12) 4227-4231
21. Drake T A., Morrissey J H., Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989 134 (5) 1087-1097
22. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004 24 (6) 1015-1022
23. Furie B, Furie B C. Mechanisms of thrombus formation. N Engl J Med 2008 359 (9) 938-949
24. Giesen P L., Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999 96 (5) 2311-2315
25. Del Conde I, Bharwani L D., Dietzen D J., Pendurthi U, Thiagarajan P, López J A. Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 2007 5 (1) 70-74
26. Bogdanov V Y., Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003 9 (4) 458-462
27. Nawroth P P., Stern D M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986 163 (3) 740-745
28. Norris L A., Weldon S, Nugent A, Roche H M. LPS induced tissue factor expression in the THP-1 monocyte cell line is attenuated by conjugated linoleic acid. Thromb Res 2006 117 (4) 475-480
29. Bevilacqua M P., Pober J S., Majeau G R., Fiers W, Cotran R S., Gimbrone M A. Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A 1986 83 (12) 4533-4537
30. Gerrits A J., Koekman C A., van Haeften T W., Akkerman J W. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes 2010 59 (6) 1487-1495
31. Egorina E M., Sovershaev M A., Olsen J O., sterud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 2008 111 (3) 1208-1216
32. Bach R R. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006 26 (3) 456-461
33. Ahamed J, Versteeg H H., Kerver M et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A 2006 103 (38) 13932-13937
34. Toomey J R., Kratzer K E., Lasky N M., Stanton J J., Broze G J. Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996 88 (5) 1583-1587
35. Parry G C., Erlich J H., Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998 101 (3) 560-569
36. Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 2000 275 (9) 6580-6585
37. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010 327 (5961) 46-50
38. Goswami D, Gowrishankar K, Bilgrami S et al. Nanoclusters of GPI-anchored proteins are formed by cortical actin-driven activity. Cell 2008 135 (6) 1085-1097
39. Davizon P, López J A. Microparticles and thrombotic disease. Curr Opin Hematol 2009 16 (5) 334-341
40. Ueba T, Nomura S, Inami N et al. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb 2010 17 (4) 342-349
41. Flaumenhaft R, Dilks J R., Richardson J et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009 113 (5) 1112-1121
42. Berckmans R J., Neiuwland R, Bing A N., Romijn F P., Hack C E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001 85 (4) 639-646
43. Habib A, Kunzelmann C, Shamseddeen W, Zobairi F, Freyssinet J M., Taher A. Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia. Haematologica 2008 93 (6) 941-942
44. Fontana V, Jy W, Ahn E R. et al. Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP. Thromb Res 2008 122 (5) 599-603
45. Chironi G N., Simon A, Boulanger C M. et al. Circulating microparticles may influence early carotid artery remodeling. J Hypertens 2010 28 (4) 789-796
46. Nomura S, Shouzu A, Omoto S et al. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. J Atheroscler Thromb 2009 16 (2) 83-90
47. Ueba T, Haze T, Sugiyama M et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 2008 100 (2) 280-285
48. Boilard E, Nigrovic P A., Larabee K et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010 327 (5965) 580-583
49. Del Conde I, Shrimpton C N., Thiagarajan P, López J A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005 106 (5) 1604-1611
50. Dietzen D J., Page K L., Tetzloff T A. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood 2004 103 (8) 3038-3044
51. Pendurthi U R., Ghosh S, Mandal S K., Rao L V. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 2007 110 (12) 3900-3908
52. Biró E, Akkerman J W., Hoek F J. et al. The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J Thromb Haemost 2005 3 (12) 2754-2763
53. Wong S W., Kwon M J., Choi A M., Kim H P., Nakahira K, Hwang D H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009 284 (40) 27384-27392
54. Carter G C., Bernstone L, Sangani D, Bee J W., Harder T, James W. HIV entry in macrophages is dependent on intact lipid rafts. Virology 2009 386 (1) 192-202
55. Chen Y, Ott C J., Townsend K, Subbaiah P, Aiyar A, Miller W M. Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G). Biochem Eng J 2009 44 (2-3) 199-207
56. Nguyen D H., Hildreth J E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000 74 (7) 3264-3272
57. Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 1999 274 (4) 2038-2044
58. Takeda M, Leser G P., Russell C J., Lamb R A. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A 2003 100 (25) 14610-14617
59. Scolari S, Engel S, Krebs N et al. Lateral distribution of the transmembrane domain of influenza virus hemagglutinin revealed by time-resolved fluorescence imaging. J Biol Chem 2009 284 (23) 15708-15716
60. Isa P, Realpe M, Romero P, López S, Arias C F. Rotavirus RRV associates with lipid membrane microdomains during cell entry. Virology 2004 322 (2) 370-381
61. Bitler A, Lev N, Fridmann-Sirkis Y, Blank L, Cohen S R., Shai Y. Kinetics of interaction of HIV fusion protein (gp41) with lipid membranes studied by real-time AFM imaging. Ultramicroscopy 2010 110 (6) 694-700
62. Coil D A., Miller A D. Enhancement of enveloped virus entry by phosphatidylserine. J Virol 2005 79 (17) 11496-11500
63. Patil A, Gautam A, Bhattacharya J. Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4+T cells. Virol J 2010 7 3
64. Li H, Dou J, Ding L, Spearman P. Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J Virol 2007 81 (23) 12899-12910
65. Adamson C S., Freed E O. Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol 2007 55 347-387
66. Christersson C, Johnell M, Siegbahn A. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10. J Thromb Haemost 2008 6 (6) 986-994
67. Liu M L., Reilly M P., Casasanto P, McKenzie S E., Williams K J. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol 2007 27 (2) 430-435
68. Becker L, Gharib S A., Irwin A D. et al. A macrophage sterol-responsive network linked to atherogenesis. Cell Metab 2010 11 (2) 125-135
69. Nomura S, Inami N, Shouzu A et al. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients. Platelets 2009 20 (1) 16-22
70. Dietzen D J., Page K L., Tetzloff T A., Bohrer A, Turk J. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase blunts factor VIIa/tissue factor and prothrombinase activities via effects on membrane phosphatidylserine. Arterioscler Thromb Vasc Biol 2007 27 (3) 690-696
71. Jeon J Y., Hwang S Y., Cho S H., Choo J, Lee E K. Effect of cholesterol content on affinity and stability of factor VIII and annexin V binding to a liposomal bilayer membrane. Chem Phys Lipids 2010 163 (45) 335-340
72. Jump D B. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002 277 (11) 8755-8758
73. Shaikh S R., Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr 2006 84 (6) 1277-1289
74. Pruemer J. Prevalence, causes, and impact of cancer-associated thrombosis. Am J Health Syst Pharm 2005 62 (22, Suppl 5) S4-S6
75. López J A., Chen J. Pathophysiology of venous thrombosis. Thromb Res 2009 123 (Suppl 4) S30-S34
76. Yu J L., Rak J W. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2004 2 (11) 2065-2067
77. Tateo S, Mereu L, Salamano S et al. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 2005 99 (1) 119-125
78. Iodice S, Gandini S, Lhr M, Lowenfels A B., Maisonneuve P. Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost 2008 6 (5) 781-788
79. Sato T, Tsujino I, Ikeda D, Ieko M, Nishimura M. Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma. Thorax 2006 61 (11) 1009-1010
80. Davila M, Amirkhosravi A, Coll E et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 2008 6 (9) 1517-1524
81. Regina S, Valentin J B., Lachot S, Lemarié E, Rollin J, Gruel Y. Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. Clin Chem 2009 55 (10) 1834-1842
82. Yokota N, Koizume S, Miyagi E et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer 2009 101 (12) 2023-2029
83. Versteeg H H., Schaffner F, Kerver M et al. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 2008 68 (17) 7219-7227
84. Schaffner F, Ruf W. Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol 2009 29 (12) 1999-2004